Sorry for the delay, but I haven't been checking this forum lately -- seems like the server has been down forever.
Anyway, regarding PCRV, you're right, the stock price development has been 'disappointing' to say the least. I had expected them to release better results for the last quarter, but as it is I now expect the improvement to take a bit more time.
The big problem with smallcaps like PCRV is that when there is some selling the price just drops, even without news. The opposite can also be true, and when combined with good news..., well, you get the point - I'm adding (EVEN more...) shares now and then between 3 and 3 3/4, and am waiting for the good news. It's not the strategy to follow if you're an impatient investor, though...
Bottom line: this company is undervalued at this price, and I think that long-term (ok, let's put it at 1 1/2 yrs) this is going to be a winner.
Then again, I'm not a professional market researcher...
Alex |